PIK3CA, BRAF , and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17

Title
PIK3CA, BRAF , and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 20, Issue 3, Pages 744-753
Publisher
American Association for Cancer Research (AACR)
Online
2013-11-12
DOI
10.1158/1078-0432.ccr-13-0606

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now